Levels of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine from volunteers after experimental exposure to NMP in dry and humid air

Toxicology Letters

Volumn 162, Issue 2-3 SPEC. ISS., 2006, Pages 139-145

  Carnerup, Martin A ^a   Spanne, Mårten ^b   Jönsson, Bo A G ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

2 Pyrrolidone; N Methyl 2 pyrrolidone; NMP metabolite

Indexed keywords

1 METHYL 2 PYRROLIDINONE;

ABSORPTION; ADULT; AIR MONITORING; ARTICLE; BIOLOGICAL MONITORING; BLOOD ANALYSIS; BLOOD SAMPLING; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TANDEM MASS SPECTROMETRY; URINALYSIS;

ADULT; ENVIRONMENTAL MONITORING; HUMANS; HUMIDITY; INHALATION EXPOSURE; MALE; MIDDLE AGED; PYRROLIDINONES; SKIN ABSORPTION; TERATOGENS;

EID: 32644433187     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2005.09.035     Document Type: Article

References (27)

1. B. Åkesson, M.A. Carnerup, and B.A.G. Jönsson Evaluation of exposure biomarkers from percutaneous absorption of N-methyl-2-pyrrolidone Scand. J. Work Environ. Health 30 2004 306 312
2. B. Åkesson, and B.A.G. Jönsson Major metabolic pathway for N-methyl-2-pyrrolidone in humans Drug Metab. Dispos. 25 1997 267 269
3. B. Åkesson, and B.A.G. Jönsson Biological monitoring of N-methyl-2-pyrrolidone using 5-hydroxy-N-methyl-2-pyrrolidone in plasma and urine as the biomarker Scand. J. Work Environ. Health 26 2000 213 218
4. B. Åkesson, and K. Paulsson Experimental exposure of male volunteers to N-methyl-2-pyrrolidone (NMP): acute effects and pharmacokinetics of NMP in plasma and urine Occup. Environ. Med. 54 1997 236 240
5. P. Akrill, J. Cocker, and S. Dixon Dermal exposure to aqueous solutions of N-methylpyrrolidone Toxicol. Lett. 134 2002 265 269
6. H. Anundi, S. Langworth, G. Johanson, M.-L. Lind, B. Åkesson, L. Friis, N. Itkes, E. Söderman, B.A.G. Jönsson, and C. Edling Air and biological monitoring of solvent exposure during graffiti removal Int. Arch. Occup. Environ. Health 73 2000 561 569
7. P.J. Becci, M.J. Knickerbocker, E.L. Raegan, R.A. Parent, and L.W. Burnette Teratogenicity study of N-methylpyrrolidone after dermal application to Sprague-Dawley rats Fundam. Appl. Toxicol. 2 1982 73 76
8. H.J. Beaulieu, and K.R. Schmerber M-Pyrol™ (NMP) use in the microelectronics industry Appl. Occup. Environ. Hyg. 6 1991 874 880
9. M.F. Boeniger, L.K. Lowry, and J. Rosenberg Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review Am. Ind. Hyg. Assoc. J. 54 1993 615 627
10. D.B. Bower Letters to the Editor: Stillbirth after occupational exposure to N-methyl-2-pyrrolidone J. Occup. Environ. Med. 39 1997 303 304
11. M.A. Carnerup, A.M. Saillenfait, and B.A.G. Jönsson Concentrations of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine following oral administration of NMP to rats Food Chem. Toxicol. 43 2005 1441 1447
12. M.A. Carnerup, B. Åkesson, and B.A.G. Jönsson Determination of 5-hydroxy-N-methyl-2-pyrrolidone and 2-hydroxy-N-methylsuccinimide in human plasma and urine using liquid chromatography-electrospray tandem mass spectrometry J. Chromatogr. B 761 2001 107 113
13. G.P.P. Fox, M. O'Regan, and T.G. Matthews The influence of ambient temperature on some commonly measured physiological variables in infants Ir. J. Med. Sci. 160 1991 249 250
14. International Program on Chemical Safety (IPCS) No. 35 N-methyl-2-pyrrolidone 2001 World Health Organization Geneva
15. B.A.G. Jönsson, and B. Åkesson Determination of N-methylsuccinimide and 2-hydroxy-N-methylsuccinimide in human urine and plasma J. Chromatogr. B 704 1997 151 158
16. B.A.G. Jönsson, and B. Åkesson N-Methylsuccinimide in plasma and urine as a biomarker of exposure to N-methyl-2-pyrrolidone Int. Arch. Occup. Environ. Health 74 2001 289 294
17. B.A.G. Jönsson, and B. Åkesson Human experimental exposure to N-methyl-2-pyrrolidone (NMP): toxikokinetics of NMP, 5-hydroxy-N-methyl-2- pyrrolidone, N-methylsuccinimide and 2-hydroxy-N-methylsuccinimide (2-HMSI), and biological monitoring using 2-HMSI as a biomarker Int. Arch. Environ. Health 76 2003 267 274
18. S. Langworth, H. Anundi, L. Friis, G. Johanson, M.-L. Lind, E. Söderman, and B.A. Åkesson Acute health effects common during graffiti removal Int. Arch. Occup. Environ. Health 74 2001 213 218
19. D. Ligocka, D. Lison, and V. Haufroid Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism Arch. Toxicol. 77 2003 261 266
20. D.W. Lundgren, and H.M. Fales Metabolism of putrescine to 5-hydroxy-2-pyrrolidone via 2-pyrrolidone J. Biol. Chem. 255 1980 4481 4486
21. B.C. Mazzachi, M.J. Peake, and V. Ehrhardt Reference range and method comparison studies for enzymatic and Jaffé creatinine assays in plasma and serum and early morning urine Clin. Lab. 46 2000 53 55
22. J.C. Miller, and J.N. Miller Statistics for Analytical Chemistry 1984 Ellis Horwood Chichester, UK
23. T. Ogiso, M. Iwaki, T. Tanino, K. Ikeda, T. Paku, Y. Horibe, and H. Suzuki Pharmacokinetics of aniracetam and its metabolites in rats J. Pharm. Sci. 87 1998 594 598
24. M. Rowland, and T.N. Tozer Clinical Pharmacokinetics: Concepts and Applications third ed. 1995 Lippincott Williams & Wilkins Philadelphia, PA, USA
25. A.M. Saillenfait, F. Gallissot, I. Langonné, and J.P. Sabaté Developmental toxicity of N-methyl-2-pyrrolidone administered orally to rats Food Chem. Toxicol. 40 2002 1705 1712
26. A.M. Saillenfait, F. Gallisso, and G. Morel Developmental toxicity of N-methyl-2-pyrrolidone in rats following inhalation exposure Food Chem. Toxicol. 41 2003 583 588
27. G.M. Solomon, E.P. Morse, M.J. Garbo, and D.K. Milton Stillbirth after occupational exposure to N-methyl-2-pyrrolidone J. Occup. Environ. Med. 38 1996 705 713